about
The TOR pathway comes of ageNO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potentialClinical Outcomes of Revascularization Strategies for Patients With MVD/LMCA Disease: A Systematic Review and Network Meta-AnalysisPotential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disordersConstruction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogenFludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activationParadoxical effects of rapamycin on experimental house dust mite-induced asthmaDual pathway therapy in acute coronary syndrome.Case scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary interventionHigh-throughput measurements of hydrogel tissue construct mechanics.Fabrication of stents with endothelial function in vitro.A novel stent coated with antibodies to endoglin inhibits neointimal formation of porcine coronary arteriesControlled release for local delivery of drugs: barriers and models.Monitoring molecular-specific pharmacodynamics of rapamycin in vivo with inducible Gal4->Fluc transgenic reporter mice.Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysisComparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry.FK506-binding protein 12 ligands: a patent review.Comparison of 9-month angiographic outcomes of Resolute zotarolimus-eluting and everolimus-eluting stents in a real world setting of coronary intervention in Korea.Enhancement of endothelialisation of coronary stents by laser surface engineering.Increased artery wall stress post-stenting leads to greater intimal thickening.A prospective, multicenter, post marketing surveillance study to evaluate the safety and effectiveness of the Superia-Sirolimus Eluting Coronary Stent System (SSECSS) implanted during routine clinical practice in India.Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study.Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trialsComparison of reendothelialization and neointimal formation with stents coated with antibodies against endoglin and CD34 in a porcine modelIn vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticlesComparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting.Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation.Development of a Novel Biodegradable Metallic Stent Based on Microgalvanic Effect.Treatment of intracranial atherosclerotic disease with a balloon-expandable paclitaxel eluting stent: procedural safety, efficacy and mid-term patency.Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease.The long-term effect of coronary stenting on epicardial and microvascular endothelial functionVascular restoration therapy and bioresorbable vascular scaffold.Early endothelialization associated with a biolimus A9 bioresorbable polymer stent in a porcine coronary model.High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents.Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in-stent restenosis.Polymers, drug release, and drug-eluting stents.Stenting of unprotected left main stem stenosis: Results from a German single-centre registry.The costs and quality-of-life outcomes of drug-eluting coronary stents: a systematic review.Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?
P2860
Q24568353-5B768A1F-EA90-4A23-AE44-C885103D7177Q24656131-3F1E7DE8-A60D-4599-9716-69016FF2FFA7Q26779886-9BE8F94B-898D-41C0-BAD1-5293CBBFFF13Q28067037-DBCBA95D-AB34-4BC3-BFF1-773C299466E7Q28222949-4FB92BEC-6190-4827-8279-39CA03E1CD4EQ28576748-509905D9-68B7-457D-91B8-CF3A0977B77BQ28728802-18EC3C3F-CE56-4E50-B371-DFF6A82EFD55Q30252011-E8AA98A5-E678-405B-85B2-8F430D2A5433Q30371026-7A162897-E0D1-4AD2-989B-8C2F40D0600AQ30493080-938EB187-FC1E-4AA2-8894-3873CA029F51Q33488585-819FC96C-367E-49E5-A321-E535C5F3487FQ33634727-9D53E50B-F9C7-483C-AFEA-714F4489A789Q34079560-1F9CD693-262D-4C2E-8ABE-6DE10D287CD3Q34192264-158273FD-DDC1-4E10-9F67-83FFB80F9857Q34452943-6159EBC3-311B-4236-89CB-D699D0BC46CFQ34888771-2E56DAB6-26E2-4DFC-9062-F236599F38B5Q34955459-CCD2EAC6-2650-4346-8BD8-06836020EAABQ34980498-5921F5C5-4545-4A25-99C3-601B34D2E171Q34987708-9CA330A8-9A61-4D6A-9BCF-C438CFFEB835Q35012092-C5EEF524-E4F8-4AA8-BB8F-0F36470363C9Q35028726-682EBAB5-2E65-4935-9A06-99B51184C1D6Q35107777-A9D2DE7F-6D02-418E-AB6D-D767C58D38C0Q35157103-909A44BA-7977-4496-95D8-C9DC288BF3F5Q35434402-106E46E5-A159-478E-9177-B073DAE0FB84Q35535453-46AF3A4C-672E-46DF-BA6D-A62C2F6E4608Q35585791-0D995E7A-04DC-48CB-B3E2-13CF71C6E91FQ35610691-DE7B06DE-98B4-4557-8069-679420BA4005Q35649420-1BFC4D32-3D07-4809-8A95-30AF3ECB1E7BQ35780741-B32F0A8D-CB1B-4D54-8E20-53171C9A9CC0Q36203503-AB47334E-8CD7-4CC1-927D-D932FF10A8CCQ36204864-6EFCB6BD-DA83-4C77-8CC1-B80C6FF4BB53Q36254261-231F58B5-8885-40BA-BBFC-0EB59EB313B6Q36345101-091C0F75-CC5F-4D3D-BD97-3E6F48DE3D16Q36374512-045FF728-2085-44E4-B585-0C233BFD56C2Q36392994-E3C4FEFD-5AF0-41FA-AFAB-ACB9EAD8A668Q36603724-B1B2F7C9-21F8-40AD-B074-A8E4C5C2E54EQ36654379-5C230A5E-BB62-4184-8885-010377F68C12Q36732017-8BDDA8BF-6011-45A1-B4BF-C2E015B4E910Q36735675-31FED83F-E34D-48F4-9BB5-831F0849E352Q36752124-4DD3C0F6-271E-4A21-A8CE-023642038EE0
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Coronary-artery stents
@ast
Coronary-artery stents
@en
Coronary-artery stents
@nl
type
label
Coronary-artery stents
@ast
Coronary-artery stents
@en
Coronary-artery stents
@nl
prefLabel
Coronary-artery stents
@ast
Coronary-artery stents
@en
Coronary-artery stents
@nl
P3181
P356
P1476
Coronary-artery stents
@en
P2093
Andrew T L Ong
Michael J B Kutryk
P304
P3181
P356
10.1056/NEJMRA051091
P407
P577
2006-02-02T00:00:00Z